We are live on ! Find out more
PC

Pavadi Capital Portfolio holdings

AUM $81.2M
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+1.88%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$91.6M
AUM Growth
-$14.5M
Cap. Flow
-$13M
Cap. Flow %
-14.15%
Top 10 Hldgs %
72.96%
Holding
22
New
4
Increased
7
Reduced
5
Closed
6

Top Buys

Rank Stock Value
1
AMN icon
AMN Healthcare
AMN
+$7.16M
2
NVST icon
Envista
NVST
+$6.79M
3
BAX icon
Baxter International
BAX
+$6.69M
4
AVTR icon
Avantor
AVTR
+$1.98M
5
MCK icon
McKesson
MCK
+$1.37M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$6.55M
2
HOLX
Hologic
HOLX
+$6.14M
3
PDCO
Patterson Companies, Inc.
PDCO
+$6.07M
4
CI icon
Cigna
CI
+$5.44M
5
LH icon
Labcorp
LH
+$5.25M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IART icon
1
Integra LifeSciences
IART
$1.29B
$7.39M 8.07%
128,758
+20,091
+18% +$1.13M
NVST icon
2
Envista
NVST
$4.44B
$7.3M 7.97%
+178,688
New +$6.79M
LNTH icon
3
Lantheus
LNTH
$6.49B
$7.26M 7.92%
87,879
+6,367
+8% +$411K
THC icon
4
Tenet Healthcare
THC
$20.5B
$7.16M 7.81%
120,432
+18,705
+18% +$1.04M
MOH icon
5
Molina Healthcare
MOH
$10.2B
$6.8M 7.42%
25,420
-2,929
-10% -$842K
BAX icon
6
Baxter International
BAX
$13.5B
$6.4M 6.98%
+157,727
New +$6.69M
AMN icon
7
AMN Healthcare
AMN
$1.3B
$6.31M 6.88%
+76,007
New +$7.16M
AVTR icon
8
Avantor
AVTR
$9.32B
$6.3M 6.87%
297,783
+87,003
+41% +$1.98M
CAH icon
9
Cardinal Health
CAH
$53.9B
$6.02M 6.58%
79,800
+772
+1% +$58.2K
MDT icon
10
Medtronic
MDT
$109B
$5.91M 6.45%
73,295
-1,978
-3% -$161K
CVS icon
11
CVS Health
CVS
$133B
$4.84M 5.29%
65,168
+3,728
+6% +$313K
HCA icon
12
HCA Healthcare
HCA
$87.2B
$4.75M 5.19%
18,024
-9,576
-35% -$2.43M
CNC icon
13
Centene
CNC
$30.7B
$4.67M 5.1%
73,939
-28,480
-28% -$2.02M
UNH icon
14
UnitedHealth
UNH
$376B
$4.62M 5.04%
9,775
+766
+9% +$370K
HUM icon
15
Humana
HUM
$43.7B
$4.54M 4.95%
9,343
-1,688
-15% -$834K
MCK icon
16
McKesson
MCK
$100B
$1.35M 1.47%
+3,791
New +$1.37M
CI icon
17
Cigna
CI
$73.8B
– –
-16,414
Closed -$5.44M
DGX icon
18
Quest Diagnostics
DGX
$25.7B
– –
-41,899
Closed -$6.55M
ELV icon
19
Elevance Health
ELV
$81.5B
– –
-8,834
Closed -$4.53M
HOLX
20
DELISTED
Hologic
HOLX
– –
-82,117
Closed -$6.14M
LH icon
21
Labcorp
LH
$25.4B
– –
-25,954
Closed -$5.25M
PDCO
22
DELISTED
Patterson Companies, Inc.
PDCO
– –
-216,412
Closed -$6.07M

Similar funds

BAM
Broadmark Asset Management San Francisco, California $80.4M AUM 29.98% 1-Year Est. Return
TCM
Tegean Capital Management New York $82.1M AUM 12.91% 1-Year Est. Return
JAM
JLP Asset Management New York $84.2M AUM 10.86% 1-Year Est. Return
HH
HP Holding New York $84.5M AUM 4.73% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
AFG
Alterity Financial Group Bangor, Maine $69.9M AUM 40.65% 1-Year Est. Return
TIMH
Tilt Investment Management Holdings New York $92.6M AUM 28.92% 1-Year Est. Return

Pavadi Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Pavadi Capital held 22 positions worth $91.6M, down 14% from $106M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Pavadi Capital withdrew a net $13M in Q1 2023, closing 6 positions and reducing 5 holdings. Its most notable exit was Quest Diagnostics, an estimated $6.55M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Pavadi Capital opened a new position in AMN Healthcare worth $6.31M.

  • Pavadi Capital's largest Q1 2023 buy was AMN Healthcare: 76,007 shares worth $6.31M.
  • Pavadi Capital added most to Avantor in Q1 2023, an estimated $1.98M increase.
  • Pavadi Capital's biggest Q1 2023 reduction was HCA Healthcare, cutting an estimated $2.43M.
  • Pavadi Capital fully exited Quest Diagnostics in Q1 2023, selling an estimated $6.55M.
  • Pavadi Capital's ten largest holdings make up 73% of its $91.6M portfolio in Q1 2023.
  • Pavadi Capital opened 4 new positions and closed 6 in Q1 2023.
  • Pavadi Capital's portfolio value fell 14% quarter-over-quarter to $91.6M.

Based on Pavadi Capital's 13F filing for Q1 2023, filed 15 May 2023.